SYDNEY: Proteomics International Laboratories Ltd (ASX: PIQ) announced on Wednesday the appointment of David Morris as Chief Executive Officer and Managing Director, effective January 19, 2026. Morris succeeds founder Dr. Richard Lipscombe, who will retire in February after 25 years leading the precision diagnostics company. Morris, a veteran healthcare and medical technology executive, has held…
Tag: healthcare
Fagron NV has acquired Amber Compounding Pharmacy, Brazil’s Vepakum
AMSTERDAM – Belgian pharmaceutical compounding giant Fagron NV announced on Friday two strategic acquisitions to expand its presence in Asia-Pacific and Brazil, coupled with a crucial regulatory license in the United States, marking a significant step in its global growth strategy. The company said it has acquired Amber Compounding Pharmacy, a leader in Singapore and Malaysia,…
Companion Spine LLC completes global acquisition of Paradigm Spine from Xtant Medical
WURMLINGEN – Companion Spine LLC, the French-American spine implant surgery specialist, announced on Tuesday the completion of its acquisition of the Paradigm Spine business globally from Xtant Medical Holdings, Inc. (NYSE: XTNT). The deal includes the flagship Coflex® Interlaminar Stabilization® device and CoFix® fusion system, along with all related subsidiaries and global business activities. The combined…
Gimv to acquire stake in Equine Care Group to fuel global expansion
ANTPWERP – European private equity firm Gimv has agreed to acquire a minority stake in Equine Care Group (ECG) from Belgian family-owned investor CNP, the companies said on Thursday, in a deal aimed at accelerating the veterinary group’s international growth. Under the definitive agreements, CNP will remain the lead strategic partner and majority owner of ECG,…
Fagron bolsters EMEA footprint with acquisitions of Amara and Magilab
BRUSSELS: Belgian pharmaceutical compounding firm Fagron said on Monday it had acquired the business of Poland’s Amara and Hungary’s Magilab to strengthen its position in the EMEA region, part of a strategy to diversify in dynamic markets. The company also said it had secured a new $225 million U.S. credit facility and received a key…
Decidr AI Industries to acquire U.S.-based Sugarwork in expansion push
SYDNEY – Decidr AI Industries Ltd (ASX:DAI) said on Wednesday it has signed a binding agreement to acquire Delaware-based Sugarwork Inc., marking its entry into the United States market as part of a global expansion strategy. The deal, structured as a scrip-for-scrip equity swap through Decidr’s newly formed U.S. subsidiary, Decidr US, will see Sugarwork…
Novo Nordisk slashes US cash prices for Wegovy and Ozempic
COPENHAGEN – Danish drugmaker Novo Nordisk said on Monday it has cut U.S. consumer prices for its weight-loss drug Wegovy and diabetes treatment Ozempic, expanding efforts by the company and the Trump administration to improve access to the blockbuster medicines. The company is reducing the monthly cost for most cash-paying patients to $349 from $499….
Medibank to acquire Australia’s primary care provider Better Medical for $159 milliond
SYDNEY: Australian health insurer Medibank Private Ltd said on Wednesday it has agreed to acquire primary care provider Better Medical for approximately $159 million, expanding its foothold in the country’s general practitioner sector. The acquisition of Better Medical, which operates a network of 61 GP and medical clinics across Victoria, Queensland, South Australia, and Tasmania,…
Novartis to buy Avidity Biosciences in $12 billion RNA therapeutics bet
ZURICH: Swiss drugmaker Novartis (NOVN.S) said on Sunday it has agreed to acquire U.S. biotech firm Avidity Biosciences (RNA.O) in a deal valued at approximately $12 billion, expanding its reach into the promising field of RNA therapeutics. Under the terms of the agreement, Novartis will pay $72 per share in cash for Avidity, representing a…
Johnson & Johnson to spin off orthopedics unit named DePuy Synthes
NEW BRUNSWICK: Johnson & Johnson said Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years. The move comes as the health-care conglomerate raised its 2025 product revenue forecast to a range of $93.5 billion…
Stellex Capital acquires Crest Ultrasonics to expand global industrial tech portfolio
NEW YORK: Stellex Capital Management, a private equity firm with more than $5 billion in assets under management, announced Friday it has acquired Crest Ultrasonics, a global manufacturer of advanced cleaning and welding equipment. Crest, headquartered in the U.S. with operations across Europe and Asia, has served industrial sectors for over six decades, including healthcare,…
Dentalcorp to be acquired by by GTCR in C$3.3 billion deal
TORONTO: Dentalcorp Holdings Ltd., Canada’s largest network of dental practices, said on Thursday it has agreed to be acquired by private equity firm GTCR in a deal that values the company at about C$3.3 billion ($2.4 billion) including debt. Under the terms of the agreement, GTCR will pay C$11.00 in cash for each share of…